CompoAtlas

Brûleur de graisse THERMOFIT Liquid

Food supplement declared in France, declaration No 2024-1-631, decision dated 15 January 2024

Brûleur de graisse THERMOFIT Liquid is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 4 rules of use apply to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
SANTE BY NUTRITION
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Flacon
Daily dose
30 ml par jour
Directions for use
Prendre 15 ml avant les deux principaux repas (midi et soir)
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, À prendre en dehors des repas, Femmes enceintes, Sous anticoagulants, Sous traitement pour la thyroïde
Objectives stated by the manufacturer (these are not authorised claims)
Détoxifiant / Draineur, Minceur / Brûleur, Gestion du poids / minceur, Minceur / Modérateur d'appétit

Declaration 324368, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Camellia sinensis (L.) KuntzeFeuilleExtrait sec aqueux2,700 mg
Betula pendula RothEcorceExtrait sec aqueux21 mg
Carica papaya L.FruitExtrait sec aqueux21 mg
Cola acuminata (P.Beauv.) Schott et Endl.GraineExtrait sec aqueux21 mg
Cynara scolymus L.FeuilleExtrait sec aqueux21 mg
Foeniculum vulgare Mill.FruitExtrait sec aqueux21 mg
Ilex paraguariensis A. St.-Hil.FeuilleExtrait sec aqueux21 mg
Melilotus officinalis (L.) Pall.Parties aériennesExtrait sec aqueux21 mg
Paullinia cupana KunthGraineExtrait sec aqueux21 mg
Peumus boldus MolinaFeuilleExtrait sec aqueux21 mg
Raphanus raphanistrum subsp. sativus (L.) DominRacineExtrait sec aqueux21 mg
Ribes nigrum L.FeuilleExtrait sec aqueux21 mg
Taraxacum campylodes G.E.HaglundFeuilleExtrait sec aqueux21 mg
Vaccinium myrtillus L.FruitExtrait sec aqueux21 mg
Zingiber officinale RoscoeRhizomeExtrait sec aqueux21 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorure de chromeChromepas de limite (données insuffisantes)25 µg

Additives

E422, E330, E202, E211

Other ingredients

Eau potable

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Une consommation excessive peut avoir des effets laxatifs. Contient de la caféine (110 mg pour 30 ml) et des épigallocatechine gallate (EGCG) (135 mg pour 30 ml). Ne pas consommer une quantité égale ou supérieure à 800 mg d’EGCG par jour. Ce produit ne doit pas être consommé si vous prenez le même jour d’autres produits contenant du thé vert ; ne doit pas être consommé par les femmes enceintes ou allaitantes et par les enfants de moins de 18 ans ; ne doit pas être consommé à jeun. Déconseillé aux personnes sous traitement anti-coagulant ; aux personnes souffrant d’allergie aux dérivés salicylés et d’intolérance aux anti-inflammatoires non-stéroïdiens et aux personnes ayant un trouble de la thyroïde. Déconseillé en cas d’obstruction biliaire ou d’autres troubles de la fonction biliaire ; en cas d'insuffisance cardiaque ou de troubles cardiaques ; en cas d'insuffisance rénale oedèmateuses ou hépatique; en cas d'ulcère gastro-duodénal [...]

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Betula pendula Roth
    Read the warning, when it applies and the studies cited

    Birch

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 August 2024

  • Foeniculum vulgare Mill.
    Read the warning, when it applies and the studies cited

    BITTER FENNEL- FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil and Tincture.

    Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

    SWEET FENNEL -FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Peumus boldus Molina
    Read the warning, when it applies and the studies cited

    BOLDO - PEUMUS BOLDUS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney or liver disorder (Brinker 2010; Barnes et al. 2007; Bradley 2006).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant or breastfeeding (EMA 2016; Brinker 2010; Bradley 2006; Mills and Bone 2005).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Taraxacum campylodes G.E.Haglund
    Read the warning, when it applies and the studies cited

    DANDELION - TARAXACUM OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder or an intestinal obstruction (Brinker 2010; Godfrey et al. 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Constipation, Flushing of the urinary tract, Indigestion, and Loss of appetite.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Applies to products providing 10 g or more of dried leaf or dried root or dried whole plant, per day or 10 mL or more of juice, per day.

    Do not use if you have diabetes or a blood pressure, kidney or cardiovascular disorder (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications or other products containing diuretics (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Zingiber officinale Roscoe
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line